Cargando…

Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women

AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-section...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Vishal R., Sharma, Sudhaa, Mahajan, Shagun, Mahajan, Annil, Khajuria, Vijay, Mahajan, Vivek, Prakash, Chander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071649/
https://www.ncbi.nlm.nih.gov/pubmed/24970986
http://dx.doi.org/10.4103/0976-7800.133994
_version_ 1782322828420317184
author Tandon, Vishal R.
Sharma, Sudhaa
Mahajan, Shagun
Mahajan, Annil
Khajuria, Vijay
Mahajan, Vivek
Prakash, Chander
author_facet Tandon, Vishal R.
Sharma, Sudhaa
Mahajan, Shagun
Mahajan, Annil
Khajuria, Vijay
Mahajan, Vivek
Prakash, Chander
author_sort Tandon, Vishal R.
collection PubMed
description AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-sectional prospective prescription audit study was carried over a period of 1 year. A total of 500 prescriptions prescribed to PMW for diagnosed HT, were identified for one point analysis. Drug prescription patterns/trends, and their adherence to JNC-7 report as well as rationality using WHO guide to good prescribing was assessed. RESULTS: In the monotherapy, category angiotensin receptor blockers (ARBs) accounted (24.8%), calcium channel blockers (CCBs) (19.4%), angiotensin converting enzyme inhibitors (ACEIs) (11%), beta blockers (BBs) (2.8%), and diuretics (2%) of the total prescription. Individually, amlodipine was maximally prescribed in 16.4%. 31.6% had double combination, whereas 2.2% and 1% had triple and four drug combinations, respectively. About 3.6% of the prescription contained antihypertensive combination along with other class of drug. ARBs + diuretic were observed in 11%, CCBs + BB 10% and ACEI + diuretic in 2.6% of the total prescriptions. Among the combination therapy amlodipine + atenolol (8.4%), telmisartan + hydrochlorothiazide (6%) and losartan + hydrochlorothiazide (4.4%) were maximally prescribed. 84.21% (P < 0.001) of the prescription showed nonadherence as per recommendations for pre-HT. 100% and 43.25% adherence rates were noticed for Stage 1 HT (P < 0.001) and Stage 2 HT (P > 0.05) patients. CONCLUSION: Antihypertensive prescription trends largely adhere to existing guidelines and are rational except polypharmacy, generic and fixed dose combinations prescribing, were some of the common pharmacologically considered irrationality noticed.
format Online
Article
Text
id pubmed-4071649
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40716492014-06-26 Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women Tandon, Vishal R. Sharma, Sudhaa Mahajan, Shagun Mahajan, Annil Khajuria, Vijay Mahajan, Vivek Prakash, Chander J Midlife Health Original Article AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-sectional prospective prescription audit study was carried over a period of 1 year. A total of 500 prescriptions prescribed to PMW for diagnosed HT, were identified for one point analysis. Drug prescription patterns/trends, and their adherence to JNC-7 report as well as rationality using WHO guide to good prescribing was assessed. RESULTS: In the monotherapy, category angiotensin receptor blockers (ARBs) accounted (24.8%), calcium channel blockers (CCBs) (19.4%), angiotensin converting enzyme inhibitors (ACEIs) (11%), beta blockers (BBs) (2.8%), and diuretics (2%) of the total prescription. Individually, amlodipine was maximally prescribed in 16.4%. 31.6% had double combination, whereas 2.2% and 1% had triple and four drug combinations, respectively. About 3.6% of the prescription contained antihypertensive combination along with other class of drug. ARBs + diuretic were observed in 11%, CCBs + BB 10% and ACEI + diuretic in 2.6% of the total prescriptions. Among the combination therapy amlodipine + atenolol (8.4%), telmisartan + hydrochlorothiazide (6%) and losartan + hydrochlorothiazide (4.4%) were maximally prescribed. 84.21% (P < 0.001) of the prescription showed nonadherence as per recommendations for pre-HT. 100% and 43.25% adherence rates were noticed for Stage 1 HT (P < 0.001) and Stage 2 HT (P > 0.05) patients. CONCLUSION: Antihypertensive prescription trends largely adhere to existing guidelines and are rational except polypharmacy, generic and fixed dose combinations prescribing, were some of the common pharmacologically considered irrationality noticed. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4071649/ /pubmed/24970986 http://dx.doi.org/10.4103/0976-7800.133994 Text en Copyright: © Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tandon, Vishal R.
Sharma, Sudhaa
Mahajan, Shagun
Mahajan, Annil
Khajuria, Vijay
Mahajan, Vivek
Prakash, Chander
Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title_full Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title_fullStr Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title_full_unstemmed Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title_short Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
title_sort antihypertensive drug prescription patterns, rationality, and adherence to joint national committee-7 hypertension treatment guidelines among indian postmenopausal women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071649/
https://www.ncbi.nlm.nih.gov/pubmed/24970986
http://dx.doi.org/10.4103/0976-7800.133994
work_keys_str_mv AT tandonvishalr antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT sharmasudhaa antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT mahajanshagun antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT mahajanannil antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT khajuriavijay antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT mahajanvivek antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen
AT prakashchander antihypertensivedrugprescriptionpatternsrationalityandadherencetojointnationalcommittee7hypertensiontreatmentguidelinesamongindianpostmenopausalwomen